Florbetapir, PET/MR and Other Nuclear Medicine Highlights
In honor of Nuclear Medicine Week, the Society of Nuclear Medicine and Molecular Imaging highlights four major advancements in the field.
It’s Nuclear Medicine Week, which means it’s a good time to reflect on some major advances in the field this year.
The Society of Nuclear Medicine and Molecular Imaging and the SNMMI Technologist Section compiled a list of four highlights:
• FDA’s approval of florbetapir for amyloid imaging
• The first results of PET/MR in clinical use
• Dose optimization efforts, including Image Gently’s guidelines for nuclear medicine
• Increased use of molecular breast imaging
Looking forward to next year, the society noted that appropriate use criteria for amyloid imaging will be released, and the FDA is expected to approve radium-223 for treatment of recurrent prostate cancer. “We are hopeful that several other radiotracers will be approved by the FDA in the coming year as well,” Frederic H. Fahey, DSc, SNMMI president, said in a statement. “In addition, SNMMI’s global initiative will also be well underway and a worldwide collaboration will be in place to advance the field.”
What are some other notable nuclear medicine moments from this year?
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 2nd 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 2nd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 2nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
